Health
Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds – News-Medical.net
Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy…
Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor of physiology & biophysics…
Continue Reading
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News24 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News19 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix